John R. Vane
born 1927
20 known books
newest first
British pharmacologist who was instrumental in the understanding of how aspirin produces pain-relief and anti-inflammatory effects and his work led to new treatments for heart and blood vessel disease and introduction of ACE inhibitors.
Books
OpenLibrary works by this author.
Improved non-steroid anti-flammatory drugs COX-2 enzyme inhibitors
1996
Prostacyclin inhealth and disease
Prostacyclin inhealth and disease
1982
Anti-Inflammatory Drugs
1978
John R. Vane, Sergio H. Ferreira, and Gustav V. R. Born
Aspirin and other salicylates
Year unknown
Asthma
Asthma
Year unknown
Clinical Significance And Potential Of Selective Cox-2 Inhibitors
Year unknown
Clinician's Manual on COX-2 Inhib...
Clinician's Manual on COX-2 Inhibition
Year unknown
Eicosanoids, aspirin, and asthma
Year unknown
Ryszard Gryglewski and John R. Vane
Endothelial Cell in Health and Di...
Endothelial Cell in Health and Disease
Year unknown
Improved Non-Steroid Anti-Inflamm...
Improved Non-Steroid Anti-Inflammatory Drugs
Year unknown
John R. Vane, Jack H. Botting, and R. M. Botting
Inflammation
Year unknown
John R. Vane and Sergio H. Ferreira
Inflammation
Year unknown
Anthony C. Allison and John R. Vane
Metabolic functions of the lung
Year unknown
New targets in inflammation
Year unknown
Jack H. Botting, John R. Vane, N. Bazan, and Jack H Botting
Prostacyclin
Year unknown
Prostaglandin synthetase inhibitors
Year unknown
Recent Advances in Prostaglandin,...
Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research
Year unknown
Helmut Sinzinger, Bengt Samuelsson, John R. Vane, Rodolfo Paoletti, and Peter Ramwell
Selective COX-2 inhibitors
Year unknown
John R. Vane and Jack H. Botting
Therapeutic Application of Prostaglandins
Year unknown
Therapeutic Roles Of Selective Co...
Therapeutic Roles Of Selective Cox-2 Inhibitors
Year unknown
Fetched from OpenLibrary. Some translations may appear as separate works.